Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms.
| Image |  |
|---|---|
| Description | scientific article published on 28 September 2016 |
| Author/s |
author: Marco Ruella Carl H. June |
| Publication date | September 28, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |